Blue Sky BioServices, founded in 2003 to serve the Boston area life sciences research hub, is now the leading Contract Research Organization (CRO) providing Gene through Screen services to the global biotech, pharma, and academic R&D market. Our customers enhance the quality and speed of their research by partnering with Blue Sky to receive world class services including; gene synthesis and bulk plasmid preparations, antibody cloning, scale-up production of recombinant proteins in multiple cell lines including mammalian, insect, bacterial and yeast, as well as antibody/protein purification and assay services such as cytotoxicity and qPCR.
Blue Sky differentiates itself with its team of experienced researchers, cutting edge process technology, and state-of-the-art laboratory facilities. Our commitment to scientific expertise and value has transformed the company into a center of excellence with unmatched quality and turnaround times.
Our suite of services is our client’s Pathway to Productivity. We are motivated by our ability to improve the overall return from the drug discovery process by enabling our partners to bring to market novel drugs faster and with increased cost-effectiveness.